Treatment of Hyperkalemia
Immediate Assessment and Risk Stratification
- The American Heart Association recommends that the urgency and intensity of treatment depends on the potassium level, ECG changes, and clinical symptoms—with severe hyperkalemia (>6.5 mmol/L) or any ECG changes requiring immediate emergency treatment 1
- The American College of Cardiology suggests verifying the result immediately with a second sample to rule out pseudohyperkalemia from hemolysis during phlebotomy 2
- Obtain an ECG immediately to assess for cardiac toxicity, as recommended by the American Heart Association 1
- ECG changes progress with severity: peaked T waves → flattened P waves → prolonged PR interval → widened QRS → sine-wave pattern → cardiac arrest, according to the American Heart Association 1
- Immediate intervention is indicated if potassium >7.0-7.5 mEq/L or ECG shows QRS widening, as suggested by the Journal of Clinical Oncology 2
Emergency Treatment
- The American Heart Association recommends administering calcium chloride 10%: 5-10 mL (500-1000 mg) IV over 2-5 minutes to stabilize the myocardial membrane 1
- Alternatively, calcium gluconate 50-100 mg/kg IV can be administered slowly with continuous ECG monitoring for bradycardia, as suggested by the Journal of Clinical Oncology 2
- Insulin + Glucose: Mix 10 U regular insulin with 25 g glucose (50 mL D50) IV over 15-30 minutes can be used to shift potassium into cells, according to the American Heart Association 1
- Nebulized albuterol: 10-20 mg over 15 minutes can also be used to shift potassium into cells, as recommended by the American Heart Association 1
- Sodium bicarbonate: 50 mEq IV over 5 minutes can be used to shift potassium into cells, particularly if metabolic acidosis is present, as suggested by the European Heart Journal 1, 3
Subacute Treatment
- The Journal of Clinical Oncology recommends eliminating all oral and IV sources of potassium for asymptomatic patients without ECG changes 2
- Sodium polystyrene sulfonate 1 g/kg with sorbitol can be used orally or rectally to remove potassium from the body, as suggested by the Journal of Clinical Oncology 2
- If on mineralocorticoid receptor antagonists (MRAs), halve the dose when potassium >5.5 mmol/L, as recommended by the European Heart Journal 3
Mild Hyperkalemia
- The American Journal of Kidney Diseases suggests implementing dietary potassium restriction as first-line intervention, including limiting high-potassium foods and avoiding salt substitutes containing potassium 6
- Presoaking root vegetables can lower potassium by 50-75%, as suggested by the American Journal of Kidney Diseases 6
Chronic Management and Prevention
- The European Heart Journal recommends targeting potassium ≤5.0 mmol/L, as recent evidence suggests this is the upper limit of safety, particularly in patients with heart failure, CKD, or diabetes 3
- Optimal range may be 3.5-4.5 mmol/L or 4.1-4.7 mmol/L based on mortality data, as suggested by the European Heart Journal 3
Special Populations
- The Journal of Clinical Oncology recommends eliminating all potassium sources as long as Tumor Lysis Syndrome (TLS) risk exists, and monitoring potassium every 4-6 hours after chemotherapy initiation 2
- The American Journal of Kidney Diseases suggests that patients on frequent hemodialysis (5 sessions/week) or peritoneal dialysis rarely need restriction and may develop hypokalemia, and investigating non-dietary causes of hyperkalemia in patients with Chronic Kidney Disease 6